Home < R & D < R&D Strategy
 
Neurotech has accumulated platform technologies in close collaboration with scientists, research institutes, and biotech companies.
Neurotech is working hard to develop new drugs with excellent efficacy and safety for stroke, brain injury, and Alzheimer's disease to fulfill medical unmet needs.
Goals for building a first-class Global R&D network are as follows:

    Maximize the research capacity of the research center
    Pipeline expansion through collaborations with industrial and educational
institutions
    Develop a global network of research organizations
    Strengthen marketing capabilities through AmKor Pharma
    Licensing technologies in/out through domestic/international strategic alliances
and securing sufficient cash flow
 
 
Untitled Document